ConductScience.org, home

Paper40293223

A Cyanobacteria-Derived RNA Aptamer Resensitizes Prostate Cancer to Hormone Therapy.

Cruz-Hernández CD and 8 others. Cancer Res, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. A Cyanobacteria-Derived RNA Aptamer Resensitizes Prostate Cancer to Hormone Therapy. Papers, record 40293223. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40293223

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Cyanobacteria-Derived RNA Aptamer Resensitizes Prostate Cancer to Hormone Therapy.
PubMed
Journal
Cancer Res
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-08-02
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aptamers, NucleotideMajor topic
Prostatic Neoplasms, Castration-ResistantMajor topic
SynechococcusMajor topic
Prostatic NeoplasmsMajor topic
Male
Humans
Animals
Mice
Nitriles
Glutamine
Xenograft Model Antitumor Assays
Cell Line, Tumor
Benzamides
Androgen Receptor Antagonists
Phenylthiohydantoin
Drug Resistance, Neoplasm
Cell Proliferation
Receptors, Androgen
Mice, Nude

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 CA233452NCI NIH HHSUnited StatesP01CA233452PubMed and NIHNIH RePORTER
W81XWH-19-1-0388U.S. Department of Defense (DOD)PubMedPubMed
CA233452National Cancer Institute (NCI)P01CA233452PubMed and NIHNIH RePORTER

Download CSV of grants

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130085248A glutamine riboswitch is a key element for the regulation of glutamine synthetase in cyanobacteria.Nucleic Acids Res2018https://conductscience.org/library/papers/30085248PubMed
220196592Fluorescent indicator displacement assay for ligand-RNA interactions.J Am Chem Soc2010https://conductscience.org/library/papers/20196592PubMed
331216023Structure and ligand binding of the glutamine-II riboswitch.Nucleic Acids Res2019https://conductscience.org/library/papers/31216023PubMed
434981784Clinical development of metabolic inhibitors for oncology.J Clin Invest2022https://conductscience.org/library/papers/34981784PubMed
538230766Cancer statistics, 2024.CA Cancer J Clin2024https://conductscience.org/library/papers/38230766PubMed
618559517Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.Cancer Res2008https://conductscience.org/library/papers/18559517PubMed
727911493RNA Secondary Structure Prediction.Curr Protoc Nucleic Acid Chem2016https://conductscience.org/library/papers/27911493PubMed
815272118Using an RNA secondary structure partition function to determine confidence in base pairs predicted by free energy minimization.RNA2004https://conductscience.org/library/papers/15272118PubMed
911313721Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system.Cell Death Differ2001https://conductscience.org/library/papers/11313721PubMed
1032580469New Frontiers in Prostate Cancer Treatment: Are We Ready for Drug Combinations with Novel Agents?Cells2020https://conductscience.org/library/papers/32580469PubMed
1129317493Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism.J Biol Chem2018https://conductscience.org/library/papers/29317493PubMed
1227973417Applications of High-Throughput Sequencing for In Vitro Selection and Characterization of Aptamers.Pharmaceuticals (Basel)2016https://conductscience.org/library/papers/27973417PubMed
1329017058Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.Cancer Cell2017https://conductscience.org/library/papers/29017058PubMed
1427665601Automated RNA 3D Structure Prediction with RNAComposer.Methods Mol Biol2016https://conductscience.org/library/papers/27665601PubMed
157559506The glutamine hydrolysis function of human GMP synthetase. Identification of an essential active site cysteine.J Biol Chem1995https://conductscience.org/library/papers/7559506PubMed
169111031Increased production of extracellular glutamate by the mitochondrial glutaminase following neuronal death.J Biol Chem1997https://conductscience.org/library/papers/9111031PubMed
1722539264Automated 3D structure composition for large RNAs.Nucleic Acids Res2012https://conductscience.org/library/papers/22539264PubMed
1817627883SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.Biomol Eng2007https://conductscience.org/library/papers/17627883PubMed
1935046532Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer.Oncogene2022https://conductscience.org/library/papers/35046532PubMed
2021988835Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.Mol Syst Biol2011https://conductscience.org/library/papers/21988835PubMed

See all 51 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42786162RNA therapeutics: current status and future directions.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42786162PubMed
42706252Nucleic acid aptamers: new methods for selection, target validation, molecular diagnostics and therapeutics.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42706252PubMed
41234842Identification and validation of RAS signaling-related genes for prognostic prediction and immunological characterization in gastric cancer.Transl Cancer Res2025https://conductscience.org/library/papers/41234842PubMed

Download CSV of cited by

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
GEOGSE232596

Source GEO

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40293223

GET https://conductscience.org/api/papers/v1/40293223/references?page=2